Ginseng Siberian (Eleutherococcus senticosus)

Siberian ginseng (Eleutherococcus senticosus) contains eleutherosides — particularly eleutheroside B (syringin) and eleutheroside E — which act as adaptogenic compounds that modulate the hypothalamic-pituitary-adrenal axis to buffer physiological stress responses. These compounds also stimulate T lymphocyte proliferation and NK cell activity, supporting both immune defense and physical endurance.

Category: European Evidence: 2/10 Tier: Moderate (some RCTs)
Ginseng Siberian (Eleutherococcus senticosus) — Hermetica Encyclopedia

Origin & History

Siberian ginseng, also known as Eleutherococcus senticosus, is a woody shrub native to Northeast Asia, including Russia, China, and Korea. It is typically sourced from the roots and rhizomes of the plant, with extracts produced via ethanol or water extraction from the dried root.

Historical & Cultural Context

Siberian ginseng has been used in Russian and Soviet folk medicine as an adaptogen to combat asthenia, fatigue, and enhance cognitive and physical endurance. Traditional Asian medicine also utilizes it for anti-fatigue and neurological benefits.

Health Benefits

• Enhances immune function, increasing T lymphocyte subsets and activation (PMID: 2963645, high quality).
• Improves endurance capacity and cardiovascular function in recreationally trained males (PMID: 21793317, moderate quality).
• Supports mental health and social functioning in heart failure patients (PMID: 15207399, moderate quality).
• Slight reduction in mental fatigue and restlessness when combined with stress management training (PMID: 23740477, moderate quality).
• Potential prophylactic effects against respiratory infections, based on narrative review of Russian trials (PMID: 34087398, low quality).

How It Works

Eleutheroside B (syringin) inhibits catechol-O-methyltransferase (COMT) and modulates glucocorticoid receptor sensitivity, reducing excessive cortisol output during stress. Eleutheroside E enhances mitochondrial ATP production and upregulates heat shock proteins (HSP70), improving cellular stress tolerance. Additionally, polysaccharide fractions stimulate macrophage phagocytosis and increase CD4+ and CD8+ T lymphocyte subsets by activating NF-κB signaling pathways.

Scientific Research

Clinical trials have shown Siberian ginseng can enhance immune function and endurance, with studies such as the double-blind RCT (PMID: 2963645) and crossover trial (PMID: 21793317) providing evidence. A narrative review of Russian trials (PMID: 34087398) supports traditional uses, although study quality varies.

Clinical Summary

A double-blind RCT (PMID: 2963645) demonstrated significant increases in T lymphocyte subsets, particularly CD4+ helper cells, in healthy volunteers supplementing with E. senticosus extract, supporting high-quality immune evidence. A moderate-quality RCT (PMID: 21793317) in recreationally trained males found improvements in VO2 max and cardiovascular endurance after 8 weeks of supplementation at 800 mg/day. Evidence for mental health benefits in heart failure patients is preliminary, drawn from smaller pilot studies with limited sample sizes. Overall, the immune and adaptogenic data are the most robust, while performance and neurological claims require larger confirmatory trials.

Nutritional Profile

Siberian Ginseng (Eleutherococcus senticosus) root and root bark contain a complex array of bioactive compounds rather than significant macronutrient content. Primary bioactives: Eleutherosides (0.6–0.9% dry weight total), comprising eleutherosideB (syringin, ~0.3–0.5% dry weight) as the primary marker compound, eleutherosideE (syringaresinol diglucoside, ~0.1–0.2% dry weight), eleutherosides A, B1, C, D, F, and G in smaller fractions. Polysaccharides (eleutherans A–G) constitute approximately 3–7% dry weight and are considered primary immunomodulatory contributors. Lignans including syringaresinol and its glycosides are present at ~0.2–0.4% dry weight. Phenolic compounds including caffeic acid, chlorogenic acid, and protocatechuic acid are present at ~0.5–1.0% dry weight collectively. Triterpenoid saponins (oleanolic acid derivatives) are present at trace levels (<0.1% dry weight). Minerals detected in root material include potassium (~1,200–1,800 mg/100g dry weight), calcium (~300–500 mg/100g dry weight), magnesium (~150–250 mg/100g dry weight), iron (~10–20 mg/100g dry weight), and zinc (~2–4 mg/100g dry weight), though these are negligible at typical supplemental doses (300–1,200 mg/day). Crude fiber content is approximately 15–25% dry weight (cellulose, hemicellulose). Protein content is approximately 8–12% dry weight but bioavailability from root preparations is minimal. Bioavailability notes: Eleutherosides undergo hepatic first-pass metabolism; eleutherosideB is hydrolyzed to syringin aglycone by intestinal microbiota before absorption. Bioavailability of eleutherosides is estimated at 20–40% in standardized extract forms versus lower in crude root powder. Standardized extracts typically normalized to ≥0.8% eleutherosides (particularly eleutherosideB+E) per European Pharmacopoeia standards.

Preparation & Dosage

Clinically studied dosages include 10 ml ethanolic extract (Eleukokk) three times daily and 800 mg/day powder for endurance benefits. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Rhodiola rosea, Ashwagandha, Schisandra, Panax ginseng, Maca root

Safety & Interactions

Siberian ginseng is generally well tolerated at standard doses of 300–1200 mg/day of dried root extract, with mild side effects including insomnia, mild hypertension, and gastrointestinal upset at higher doses. It may potentiate anticoagulants such as warfarin by modulating CYP450 enzymes (notably CYP2C9), and co-administration with digoxin has been reported to falsely elevate serum digoxin levels. It is contraindicated in individuals with autoimmune conditions (e.g., lupus, rheumatoid arthritis) due to immune stimulation, and those with hormone-sensitive conditions should use caution given weak estrogen-like activity. Pregnancy and breastfeeding safety has not been established in controlled trials; avoidance is recommended during these periods.